New Zealand markets closed
  • NZX 50

    11,641.85
    -12.71 (-0.11%)
     
  • NZD/USD

    0.6385
    +0.0011 (+0.18%)
     
  • NZD/EUR

    0.6082
    +0.0030 (+0.49%)
     
  • ALL ORDS

    7,503.50
    -50.50 (-0.67%)
     
  • ASX 200

    7,301.50
    -52.90 (-0.72%)
     
  • OIL

    81.23
    +0.01 (+0.01%)
     
  • GOLD

    1,802.00
    -13.20 (-0.73%)
     
  • NASDAQ

    11,911.00
    -130.89 (-1.09%)
     
  • FTSE

    7,555.61
    -2.88 (-0.04%)
     
  • Dow Jones

    34,254.52
    -140.49 (-0.41%)
     
  • DAX

    14,509.49
    +19.19 (+0.13%)
     
  • Hang Seng

    18,675.35
    -61.09 (-0.33%)
     
  • NIKKEI 225

    27,777.90
    -448.18 (-1.59%)
     
  • NZD/JPY

    86.4070
    +0.2420 (+0.28%)
     

The Zacks Analyst Blog Highlights UnitedHealth Group, Johnson & Johnson, Chevron, The Home Depot and AT&T

For Immediate Release

Chicago, IL – September 27, 2022 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: UnitedHealth Group Inc. UNH, Johnson & Johnson JNJ, Chevron Corp. CVX, The Home Depot, Inc. HD, and AT&T Inc. T.

Here are highlights from Monday’s Analyst Blog:

Top Stock Reports for UnitedHealth, Johnson & Johnson and Chevron

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth Group Inc., Johnson & Johnson and Chevron Corp.. These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

You can see all of today's research reports here >>>

UnitedHealth shares have outperformed the Zacks Medical - HMOs industry (+25.3% vs. +24.6%) and the S&P 500 (+25.3% vs. -18.1%) index over the past year . The Zacks analyst believes that the company's top line has been growing and the momentum should continue in the years ahead on the back of a strong market position and an attractive core business that continues to be driven by new deals, renewed agreements and expansion of service offerings.

UNH's Government business remains well-poised for growth. A sturdy balance sheet enables investments and prudent capital deployment through share buybacks and dividends. However, softness in commercial business due to COVID-induced volatilities persists. Also, the rising operating costs are hurting the company's bottom line.

(You can read the full research report on UnitedHealth here >>>)

Johnson & Johnson's shares have advanced +2.2% over the past year against the Zacks Large Cap Pharmaceuticals industry's gain of +6.0%. The Zacks analyst believes that J&J's diversification makes it relatively resilient amid macroeconomic turmoil. Its Pharma unit is performing at above-market levels, supported by its blockbuster drugs, Darzalex and Stelara, and contribution from newer drugs, Erleada and Tremfya. Sales in the MedTech unit are recovering in 2022 and the company is focusing on growing this business through new products. J&J is making rapid progress with its pipeline and line extensions.

However, sales in the Consumer and MedTech units are being hurt by inflationary pressure. Headwinds like generic competition and pricing pressure continue. Though J&J has taken meaningful steps to resolve its talc and opioid litigation, they continue to remain an overhang on the stock.

(You can read the full research report on Johnson & Johnson here >>>)

Chevron shares have outperformed the Zacks Oil and Gas - Integrated – International industry over the past year (+40.6% vs. +25.6%). The Zacks analyst believes that the company is considered one of the best-placed global integrated oil firms to achieve sustainable production ramp-up. America's No. 2 energy company's existing project pipeline is among the best in the industry, thanks to its premier position in the lucrative Permian Basin.

However, Chevron was not immune to the commodity price crash of 2020, forcing it to cut spending substantially. The company's high oil price sensitivity is a concern too. Moreover, the supermajor's 10-year reserve replacement ratio of 100% is indicative of its inability to replace the amount of oil and gas produced.

(You can read the full research report on Chevron here >>>)

Other noteworthy reports we are featuring today include The Home Depot, Inc., and AT&T Inc..

Why Haven't You Looked at Zacks' Top Stocks?

Our 5 best-performing strategies have blown away the S&P's impressive +28.8% gain in 2021. Amazingly, they soared +40.3%, +48.2%, +67.6%, +94.4%, and +95.3%. Today you can access their live picks without cost or obligation.

See Stocks Free >>

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com                       

https://www.zacks.com

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
AT&T Inc. (T) : Free Stock Analysis Report
 
Chevron Corporation (CVX) : Free Stock Analysis Report
 
UnitedHealth Group Incorporated (UNH) : Free Stock Analysis Report
 
Johnson & Johnson (JNJ) : Free Stock Analysis Report
 
The Home Depot, Inc. (HD) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research